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ABSTRACT
Motivation: Automatic classiﬁcation of high-resolution mass
spectrometry proteomic data has increasing potential in the early
diagnosis of cancer. We propose a new procedure of biomarker
discovery in serum protein proﬁles based on: (i) discrete wavelet
transformation of the spectra; (ii) selection of discriminative wavelet
coefﬁcients by a statistical test and (iii) building and evaluating
a support vector machine classiﬁer by double cross-validation
with attention to the generalizability of the results. In addition
to the evaluation results (total recognition rate, sensitivity and
speciﬁcity), the procedure provides the biomarker patterns, i.e. the
parts of spectra which discriminate cancer and control individuals.
The evaluation was performed on matrix-assisted laser desorption
ionization time-of-ﬂight (MALDI-TOF) serum protein proﬁles of 66
colorectal cancer patients and 50 controls.
Results: Our procedure provided a high recognition rate (97.3%),
sensitivity (98.4%) and speciﬁcity (95.8%). The extracted biomarker
patterns mostly represent the peaks expressing mean differences
between the cancer and control spectra. However, we showed that
the discriminative power of a peak is not simply expressed by its
mean height and cannot be derived by comparison of the mean
spectra. The obtained classiﬁers have high generalization power
as measured by the number of support vectors. This prevents
overﬁtting and contributes to the reproducibility of the results, which
is required to ﬁnd biomarkers differentiating cancer patients from
healthy individuals.
Availability: The data and scripts used in this study are available at
http://www.math.uni-bremen.de/∼theodore/MALDIDWT.
Contact: theodore@math.uni-bremen.de
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Colorectal cancer (CRC) is one of the most common malignancies
and remains a principal cause of cancer-related morbidity and
mortality. The early detection of cancer is essential for a successful
∗To whom correspondence should be addressed.
treatment. Currently, the colonoscopy is used to detect early stage
lesions, but this is an invasive and relatively expensive method.
Therefore, a different method would be desirable relaying on easily
accessible body ﬂuids, like serum. A sensitive blood test might not
only detect early stage malignancies, but also premalignant lesions
(not part of this study), thereby increasing the chance of survival
considerably.
The use of mass spectrometry for searching serum biomarkers
in cancer diagnostics was suggested by Petricoin et al. (2002)
but was factually ﬂawed. Second-generation studies discovered the
importance of avoiding bias and overﬁtting as well as the need
of validation (Ransohoff, 2004). Here a procedure is presented
for biomarker extraction from matrix-assisted laser desorption
ionization time-of-ﬂight (MALDI-TOF) serum protein proﬁles
constructed with attention to generalizability of the achieved results.
Recently,deNooetal.(2006)demonstratedthefeasibilityofmass
spectrometry based protein proﬁling for the discrimination of CRC
patients from healthy individuals, using quite simple classiﬁcation
methods. This motivated us to develop an advanced procedure
of biomarker extraction using the ideas proposed in Schleif
et al. (2007): (i) discrete wavelet transformation (DWT) of the
spectra, (ii) features (wavelet coefﬁcients) selection by statistical
testing and (iii) support vector machine (SVM) classiﬁcation, see
Supplementary Figure 1 for an overall scheme.
Our new procedure presented in this article goes signiﬁcantly
beyond that of Schleif et al. (2007): (i) The actual approach does
notonlygiveaclassiﬁcationofspectra,butalsosupportsthelocation
and scoring of spectral features which are putative biomarkers. For
this goal, we propose additional wavelet reconstructions to visualize
the results; (ii) The classiﬁer assessment is now using a double
cross validation scheme to avoid a possible bias of the results;
(iii) The feature selection is also included within the double cross
validation to avoid potential biases of the performance estimation
and (iv) Finally, we investigated the role of the statistical testing
and compared different tests and adjustments. In addition to the
Kolmogorov–Smirnov (KS) test we also used a Mann–Whitney
(MW) test for feature selection and also applied a Benjamini–
Yekutieli(BY)multipletestadjustmenttogetmoreconﬁdenceabout
the inﬂuence of the feature selection techniques. Finally, we added a
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Table 1. Patient characteristics and distribution across plates
Patients Controls
Number 64 48
Mean age (range) 67.2(37–89) 52.2(29–78)
Male/female ratio 35/29 21/27
Number on plate 1/2/3 25/22/17 17/16/15
detailed analysis of the robustness of the classiﬁcation as a function
of the number of selected features and the number of resulting
support vectors. This is helpful to estimate the generalizability of
the resulting classiﬁcation model.
Our procedure was evaluated on new publicly available datasets
obtained according to the randomized block design, which helps
to minimize impact of potential confounding factors on the
experimental side and, thus also to avoid bias.
Being aware of the problem of non-reproducibility of promising
results in high-throughput mass spectrometry (Check, 2004;
Coombes et al., 2005; Ransohoff, 2004), we assessed the general-
ization power of the constructed classiﬁers as follows.
For different types of the feature selection, the conservativeness
was investigated as considering fewer features reduces the risk of
overﬁtting. Moreover, we thoroughly analyzed the generalization
error of the classiﬁers measured as the number of support vectors
used for the classiﬁcation (Bartlett and Shawe-Taylor, 1999).
2 METHODS
2.1 Serum protein proﬁling
Serum samples were obtained from a total of 66 CRC patients one day
before surgery and 50 healthy volunteers (Table 1). All stages of disease
were present in the patient group in comparable proportions. The Tumor-
Nodes-Metastases (TNM) stages are I-IIIc according to the AJCC Cancer
Staging Manual (6th edn). Moreover, patients without invasive carcinoma
but no premalignant cases were included. Informed consent was obtained
from all patients and the Medical Ethical Committee approved the study.
Blood was collected in a 10cc serum separator vacutainer tube and
centrifuged 30min later at 3000r.p.m. for 10min. Serum samples were
distributedinto0.5mlaliquotsandstoredat−70◦Cuntiltheexperiment.The
isolation of peptides from serum was performed using the magnetic beads
based hydrophobic interaction chromatography (MB-HIC) kit from Bruker
Daltonics (Bremen, Germany), according to the manufacturers protocol. α-
Cyano-4-hydroxycinnamic acid (0.3g/l in ethanol:acetone 2:1) was used
as matrix. All sample preparation steps were performed on a 8-channel
Hamilton STAR pipetting robot (Hamilton, Martinsried, Germany). Using
a randomized block design, correcting for demographic and pathological
variables, all samples were spotted in quadruple on 3 plates (Table 1).
The plates were measured on three consecutive days, Tuesday to Thursday.
MALDI-TOF mass spectrometry measurements were performed using
an Ultraﬂex TOF/TOF instrument (Bruker Daltonics), equipped with
a SCOUT ion source and measured in linear mode. All unprocessed
spectra were exported in standard 8-bit ASCII format. They consisted of
approximately 65400 mass-to-charge ratio (m/z)-values, covering a domain
of 960–11170Da. For more information, see de Noo et al. (2006).
2.2 Low-level analysis
The data have been exported using ClinProTools (CPT) software (version
2.2, Bruker Daltonics) where we performed recalibration, top-hat baseline
correction (all with default parameters), outlier detection, and as in the
reference paper, data reduction with factor 4. We found two additional
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Fig. 1. Mean spectra for the cancer and control group (inverted, gray
spectrum) after low-level processing.
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Fig. 2. Scheme of calculation of APPDWT and CONVDWT coefﬁcients,
the bior3.7 wavelet and its scaling function. Ai(Di) denote approximation
(detail) coefﬁcients of the i-th level, n is the maximum level (10 in our case).
Note that An belongs to both the APPDWT and CONVDWT coefﬁcients.
outliers in the control group compared with the reference paper, but included
one more cancer spectrum in the dataset for classiﬁcation. The interpolation
of all cancer and control spectra on one grid has been done using Matlab.At
the end, we had 64 cancer and 48 control spectra of length 16331 covering a
domain of 960–11163Da. The mean spectra both for the cancer and control
groups are depicted in Figure 1.
2.3 Discrete Wavelet Transformation
DWT is an important tool in signal processing, in particular for its superior
properties of denoising and compression. The central idea of DWT is to ﬁnd
alosslessmulti-scalerepresentationofdatabymeansofwaveletcoefﬁcients.
Informallyspeaking,eachcoefﬁcientrepresentsacontributionforsomescale
and position.Avast literature on DWTis available, covering both theoretical
and applied issues, see e.g. Mallat (1999). DWT has been useful for MS data
processing for many years, see a review of Leung et al. (1998) for early
references.
Given a spectrum, the DWT was applied to produce a set of wavelet
coefﬁcients which are further used for feature selection and classiﬁcation.
We evaluated two approaches of calculating wavelet coefﬁcients. First,
as usual in DWT, we computed detail coefﬁcients of each level together
with the approximation coefﬁcients of the maximum level. Second, we
considered the approximation coefﬁcients of all levels, instead of the
detail coefﬁcients (Figure 2). We denote these approaches CONVDWT and
APPDWT,respectively.APPDWTisbettersuitedforbiomarkervisualization
andpeakdetectionsincebeingreconstructed,eachapproximationcoefﬁcient
produces the scaling function (a narrow bump) but not the wavelet (an
oscillating function) obtained for a detail coefﬁcient (Figure 2).The numbers
of calculated detail/approximation DWT coefﬁcients at each level (level
number in brackets) are: 8173 (1), 4094 (2), 2054 (3), 1034 (4), 524 (5),
269 (6), 142 (7), 78 (8), 46 (9), 30 (10). This accounts for a total of 16444
coefﬁcients.
The bi-orthogonal bior3.7 wavelet was used, because the shape of its
scaling function closely matches the peak pattern of MALDI-TOF spectra
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(Schleif et al., 2007). This is a favorable property of the selected wavelet,
since for such a wavelet large values of DWT coefﬁcients can be associated
with peaks and a peak is represented by only a few dominant coefﬁcients.
Using wavelet coefﬁcients for classiﬁcation has the following advantages.
First, DWT provides automatic denoising as it separates noise contribution
(generating coefﬁcients of the ﬁrst-scale levels) and signal contribution.
Even if we do not carry out the denoising explicitly, this property of DWT
helps the statistical feature selection (introduced below) to ﬁnd signiﬁcant
differences between the two classes. In case of overlapping peaks, the peak
picking process becomes complicated and it is usually required to specify
a typical a priori peak width. The DWT approach does not require such
a speciﬁcation. However, if there is information available about the m/z
range and the expected width of the peaks this can improve the performance
signiﬁcantly.
2.4 Statistical feature selection
In order to ﬁnd those wavelet coefﬁcients which differentiate between
cancer and control spectra, we used non-parametric statistical testing of
the null hypothesis Hi that no distinction between cancer and control
groups is expressed by the i-th coefﬁcient. Only the coefﬁcients signiﬁcantly
rejecting the hypothesis are used for classiﬁcation. Note that the applied
test of difference is aimed not at extraction of peaks but at extraction
of discriminative features. The statistical testing signiﬁcantly reduces the
number of coefﬁcients.
For the statistical feature selection we evaluated the KS and MW tests
(signiﬁcance level 0.05), which are both non-parametric and distribution
free tests for assessing whether two samples of observations come from
the same distribution or not. Since we compare thousands of coefﬁcients
simultaneously, the so-called ‘multiple testing’ adjustment of p-values has
to be applied. The aim of the adjustment is to control the type I error
rate deﬁned with respect to the multiple testing approach. Among the most
popular adjustments are the Bonferroni (Bonf) and the Benjamini–Hochberg
(BH) adjustment.
Bonfisperhapsthebestknownadjustmentprocedureinmultipletesting.It
strongly controls the family-wise error rate (FWER) which is the probability
of at least one false positive within the set of tests. BH strongly controls
the false discovery rate (FDR) for independent test statistics. The FDR is
the expected proportion of type I errors among the rejected hypotheses. In
additiontotheBonfandBH,weevaluatedtheBYadjustmentwhichstrongly
controls the FDR for an arbitrary dependence structure. We considered
BY presupposing dependence between DWT coefﬁcients. As discussed, the
shape of the chosen wavelet matches a typical peak shape quite well but is
still not perfect. Hence, a large peak commonly generates not only one large
wavelet coefﬁcient, but several ones positioned close to the peak maximum.
Under the condition of complete null hypotheses (all coefﬁcients do not
distinguish cancer and control groups) the FDR would be equivalent to
the FWER. Obviously, this is not expected. In this case, the procedures
controlling FWER (Bonf) are more conservative than those controlling FDR
(BH, BY), because FWER-controlling procedures suppress false positives.
FDR-controlling procedures tolerate a few false positives provided that their
number is small compared to the number of all rejected hypotheses. For
further discussion on multiple testing approaches, see Dudoit et al. (2003).
2.5 SVMs
The selected discriminative DWT coefﬁcients are used as input data for
the classiﬁcation. For the classiﬁcation, we used a SVM of type C-SVM
with a gaussian kernel. SVM is a powerful and popular machine learning
technique, widely used for classiﬁcation and extensively applied in biology
(Noble,2004).TheSVMtheoryandalgorithmsaredescribedinmanypapers
and books. For a short introduction to SVM from the biological viewpoint,
see Noble (2006).
The main idea of SVM is to establish a maximum margin classiﬁer. Linear
in its basic formulation, SVM classiﬁers become non-linear with respect to
Fig. 3. The i-th step of double CV used for simultaneous parameters
estimation and prediction assessment, i goes through all the given spectra.
the given data by exploiting a kernel function or, simply, a kernel. The most
often used types of kernels are linear, polynomial and the gaussian kernels.
We exploited the gaussian kernel as advised by Schleif et al. (2007) (the
linear kernel has also been used, but gave lower recognition rates, results not
shown).
The C-SVM classiﬁer we used, has a parameter C, which is a trade-off
between maximization of the classiﬁer capacity and minimization of the
number of misclassiﬁed examples. Together with the width parameter γ
of the gaussian kernel they represent the so-called SVM hyperparameters
which should be optimized for classiﬁcation. A variety of implementations
of SVM are available; we used the Bioinformatics Toolbox 2.5 of Matlab
7.4 (R2007a).
SVM was selected for classiﬁcation because of: (i) the small number
of hyperparameters and their interpretability, (ii) theoretically substantiated
goodgeneralizationpropertiesofSVMclassiﬁers,(iii) sparsenatureofSVM
classiﬁers, i.e. the classiﬁer is built only on a representative part of the data.
The data vectors used (in our case each one contains the wavelet coefﬁcients
calculatedforaspectrum)arecalledthesupportvectorsandtheothervectors
are not taken into account for classiﬁcation. A disadvantage of SVM is
the required runtime to optimize the hyperparameters. For routine classiﬁer
generation more efﬁcient alternatives than a simple grid search might be
required. The classiﬁcation of additional spectra is not a performance issue.
2.6 Double cross-validation
For the choice of SVM hyperparameters C and γ we used the double cross-
validation (CV) paradigm according to Mertens et al. (2006). Double CVis a
bias-reducingschemeofsimultaneousparametersestimationandassessment
of the classiﬁer.Although double CV dates back to 1974 (Stone, 1974), this
approach is still rather new in the ﬁeld of mass spectrometry. In this ﬁeld, to
our knowledge double CV was ﬁrst introduced by Mertens et al. (2006) (see
this reference for a historical review on double CV) as well as by de Noo
et al. (2006) and these references are followed in the essential points.
The double CV scheme consists of an outer validation loop and an inner
training loop. We used leave-one-out CV for the outer loop and 5-fold CV
for the inner loop. In this setting, the i-th step of the double CV scheme
consists of two stages: (i) for the i-th element of the data the choice of
hyperparametersisdoneusing5-foldCVontheleftoverpart(withthefeature
selection performed within the inner loop), then (ii) the feature selection is
done on the leftover part. Finally a classiﬁer is trained with the optimized
hyperparameters using all but the i-th spectrum. This classiﬁer is applied
for classiﬁcation of the excluded i-th spectrum. The total recognition rate
(TRR, the fraction of correctly classiﬁed spectra), sensitivity and speciﬁcity
are calculated in the outer validation loop. The scheme of the i-th step of the
double CV is shown in Figure 3.
As usual for SVM, given a train set and a test set, the hyperparameters C
and γ are optimized by grid search. The TRR is used as the minimization
criterion. At the i-th step of the outer loop, the TRR on all but the i-th
spectrum is estimated using 5-fold CV and the hyperparameters minimizing
this value are selected. Recall that the ﬁnal double CV TRR (presented in
Table 2) is calculated in the outer loop.
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Table 2. Double CV classiﬁcation results for the detection of cancer using the proposed procedure
DWT type Test TRR Sensitivity Speciﬁcity Number of coefﬁcients Mean number of SV
BH Bonf BY BH Bonf BY BH Bonf BY BH Bonf BY BH Bonf BY
APPDWT KS 96.4 96.4 96.4 96.9 98.4 98.4 95.8 93.8 93.8 6219 1545 3392 55 44 49
APPDWT MW 96.4 97.3 97.3 96.9 98.4 96.9 95.8 95.8 95.8 7068 1784 3920 56 43 52
CONVDWT KS 95.5 95.5 96.4 96.9 96.9 96.9 93.8 93.8 95.8 603 299 419 66 54 49
CONVDWT MW 94.6 94.6 96.4 95.3 96.9 96.9 93.8 91.7 95.8 613 303 438 81 61 55
APPDWT and CONVDWT specify the ways of wavelet coefﬁcients calculation. Column ‘Number of coefﬁcients’ contains the number of discriminative coefﬁcients selected.
Column ‘Mean number of SV’ shows mean number of support vectors describing the generalizability of the classiﬁer: a large number indicates overﬁtting.
Note that a step of the double CV with leave-one-out CV in the outer loop
and 5-fold CV in the inner loop simulates clinical diagnosis with 5-fold CV
used for training. In double CV, this step is repeated for each spectrum thus
providing the TRR and other characteristics of the considered prediction
procedure. After method evaluation, having a training dataset and a new
patient sample coming in, we (i) optimize C and γ using 5-fold CV on the
training data, (ii) select discriminative coefﬁcients of the training dataset,
(iii) apply the classiﬁer with the best parameters to the extracted features of
the new sample spectrum.
2.7 Biomarkers
Having obtained the classiﬁcation results, we are interested to interpret
the wavelet coefﬁcients used in the classiﬁcation and to identify putatitive
biomarkers. For this purpose, we calculated the parts of the spectra
represented by the selected wavelet coefﬁcients. Given the selected wavelet
coefﬁcients for each spectrum, we reconstructed the m/z ranges represented
by these coefﬁcients. Then we computed the class-discriminating m/z ranges
by averaging the resulting spectral components of all spectra within each
class. For CONVDWT coefﬁcients, the reconstruction is done using inverse
wavelet transformation. Unfortunately, an inverse wavelet transformation
is not possible for APPDWT coefﬁcients. Therefore, for each level of the
DWT we reconstructed the one-level signal from the selected approximation
coefﬁcients. From the produced one-level signals we took the maximum
value for each m/z-value.
Moreover, in order to ﬁnd the most class-discriminative features of the
spectra,westudiedthepartsofthespectrawhichcorrespondtoaprespeciﬁed
number of the most signiﬁcant wavelet coefﬁcients, i.e. the coefﬁcients
having the lowest P-values of the statistical test.
3 RESULTS
3.1 Classiﬁcation results
The results of applying the double CV simultaneous parameters
choiceandclassiﬁerassessmentschemetogetherwiththeintroduced
wavelet-based approach are given in Table 2. The achieved TRR,
sensitivity and speciﬁcity for all tests and adjustments are higher
than those reported by de Noo et al. (2006) which are 92.6%, 95.2%
and 90.0%, respectively (even taking into account that we excluded
one additional outlier). The one cancer sample misclassiﬁed by all
theclassiﬁershaslateTNMstage(IIIc).UsingAPPDWTgavebetter
recognition rates than CONVDWT and the combination of MW and
Bonf (or BY) forAPPDWT provided the best results (97.3% TRR).
Notethattheachievedsensitivityishigherthanthespeciﬁcityasalso
reported by de Noo et al. (2006). The runtimes (15+9 grid points,
112×(5+1) train-test runs for each grid point) on an Intel 2.66GHz
PC were ∼9h (KS, Bonf), 17h (KS, BH/BY), 22h (MW, Bonf)
and 30h (MW, BH/BY). We also compared our procedure with
CPT v.2.2. Since double CV is not included in CPT yet, we used
the leave-one-out CV evaluation both in CPT and our procedure.
Moreover,thetechnicalreplicateshavenotbeenaveraged(thatisnot
implemented in CPT) resulting in 438 spectra. Other preprocessing
steps (Section 2.2) were the same. The calculated TRR values are
98.63% produced by our procedure (APPDWT, MW, Bonf) versus,
atbest,98.46%forCPT(SVM,automaticnumberofpeaks,KNN3).
This number is only slightly smaller than the one obtained with our
procedure and the difference can not be considered to be signiﬁcant.
However, note that the peak picking which depends on all spectra is
not included in the leave-one-out CV of CPT. The high-recognition
accuraciesdemonstratetheeffectivenessoftheclassiﬁerinrevealing
the difference between cancer and control spectra.
3.2 Generalization properties
As shown, our classiﬁcation procedure provides an improved
accuracy for cancer detection, and the TRR is several percent better
than those originally reported for the same data by de Noo et al.
(2006).However,themostimportantprobleminproteomicproﬁling
today is not to gain several percent advance but to ﬁnd reproducible
biomarkers. As Ransohoff (2004) concluded, it is crucial to assess
reproducibility of results in some direct way.
Being aware of this problem, we used double CV with disjoint
datasets for optimization and validation. The whole procedure
(DWT, feature selection, classiﬁcation) is evaluated in the inner
loop of the double CV. This helps to avoid possible bias in results
and to make them reproducible. Furthermore, we investigated the
generalizability of the derived classiﬁers as follows.
First, we compared the conservativeness of the statistical test
used, in other words, the fraction of wavelet coefﬁcients which are
not rejected by the test. This question is related to the ‘overﬁtting’
problem, because in general a smaller dimension of the data used
for the classiﬁcation results in a reduced risk of overﬁtting. Table 2
shows the number of selected coefﬁcients for all the tests and
adjustments both for CONVDWT and APPDWT. Despite the same
TRR provided, MW with Bonf is better than MW with BYsince the
former combination selects signiﬁcantly fewer coefﬁcients.
Investigating the conservativeness of the statistical tests is an
opportunity to study the generalization properties of the provided
classiﬁers beyond the set of training spectra. An important
characteristic of any SVM classiﬁer is the use of only a part of
the given vectorial data, the so-called support vectors. If fewer
support vectors are used, the classiﬁer is more likely to give good
results for an extended set of samples and it is less likely be overﬁt
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Fig. 4. (a) The class-discriminating parts of spectra (MW, Bonf, APPDWT) against the mean spectra (control data are shifted in intensity for better viewing)
in the interval 960–3500Da (no discriminative peaks above 3500Da). (b) Difference between these parts in the interval 1100–2100Da. Positive (negative)
peaks relate to the cancer (control) spectra.
(Bartlett and Shawe-Taylor, 1999). Table 2 shows the mean number
of support spectra used in the outer loop of the double CV.
For the combination (MW, Bonf) the number of support vectors
is 43 on average, whilst the training dataset is of size 111. Therefore
the classiﬁcation procedure is able to represent the information
discriminating between cancer and control groups with one third
of the training spectra.
Also,thegeneralizabilitywasestimatedinthefollowingempirical
way. In the outer loop of a double CV we classiﬁed spectra with
additional normal distributed noise that simulates classiﬁcation of
newdatawithmodelstrainedontheoriginaldata.Thenoisestandard
deviation was 0.31 which is twice the real noise estimated in the
m/z-interval [1200,2400]. For the achieved classiﬁcation results see
SupplementaryTable1.Bonf-classiﬁersaremoregeneralthanothers
as their TRR is only slightly diminished [96.4% for (MW, Bonf)
versus 66.1% and 86.6% for (MW, BH) and (MW, BY), using
APPDWT coefﬁcients].
Finally, we investigated the stability of the feature selection
procedure using double CV. Therefore, we compared the features
extracted at each outer iteration of the double CV (Supplementary
Figure 2). Except for tiny variations, the feature extraction is very
stable. Moreover, we ran the whole classiﬁcation procedure with
the feature selection performed in advance outside of the double
CV. The provided classiﬁcation results were very similar to those
presented in Table 2 which indirectly conﬁrms the stability of the
feature selection procedure.
3.3 Biomarkers
The class-discriminating parts of the cancer and control spectra,
computed as described in Section 2.7 for the MW test and the Bonf
adjustment using APPDWT coefﬁcients are shown in Figure 4a.
Even though the scale of the wavelet coefﬁcients was not speciﬁed,
the discriminating parts consist of peaks which are all positioned in
the m/z-interval 1000–3300Da (mostly inside 1200–2050Da).
The fact that discriminative coefﬁcients represent peaks demon-
strates the ability of DWT to extract biologically relevant features.
InFigure4b,thedifferencebetweentheclass-discriminatingparts
ofthespectra(cancerminuscontrol)ispresentedandtheeightpeaks
with the largest difference are marked: 1208, 1265, 1352, 1467Da
for control spectra and 1692, 1780, 1867, 2024Da corresponding to
cancer spectra, respectively.The difference pattern is very similar to
the difference of the mean spectra and to the correlation coefﬁcients
presented by de Noo et al. (2006), Figure 3, although our pattern
is more detailed. In the results of de Noo et al. (2006), the control
peak at 1619 Da (difference in intensity −2.6) is overlooked, the
cancer peak at 1692Da is almost unnoticeable, and the large peak
at 2024Da is not separated from the tiny neighbor peak at 2013Da.
In the remainder of this section we consider the most
discriminative parts of the extracted biomarker patterns. Based
on the results of the statistical feature selection, we deﬁne the
discriminative power (the measure of difference) between cancer
and control spectra at some m/z-value through P-values as follows:
in DWT several scales are considered (we used 10 scales, the
ﬁrst represents the ﬁnest details of the spectra) and for each scale
the wavelet coefﬁcients at all possible positions (m/z-values) are
calculated. Then for each wavelet coefﬁcient (corresponding to
some position and some scale) the statistical difference between its
values for the cancer and control data is calculated by means of the
statistical test of difference. Thus, the discrimination power at some
position and on some scale is expressed by a P-value. As usual, the
smaller the P-value, the more discriminative is the position on this
scale.
Figure 5a depicts the mean spectra difference and the P-values
(using a log10-scale) calculated for theAPPDWT coefﬁcients (MW,
Bonf) in the interval 1100–2460 Da. In this diagram, each cell
corresponds to a P-value and the width of the cell depends on the
scale.ThecellsarecoloredaccordingtotheirP-values(log10-scale).
Darker cells indicate more discriminative wavelet coefﬁcients.
One can clearly see the correspondence between the large peaks
expressing the mean spectra difference and the p<10−10 (dark
cells in Figure 5a), especially on the ﬁrst levels where wavelets
providesufﬁcientlyﬁneresolution.Thisillustratesthatourstatistical
featureselectiondoesnotmissthelargemeandifferencebetweenthe
cancer and control data. Moreover, these results correlate with the
biomarker patterns presented in Figure 4b which mostly represent
these peaks.
Thus, the P-values of the wavelet coefﬁcients give an estimate of
thediscriminativepoweroffeaturesatdifferentscalesandpositions.
647T.Alexandrov et al.
(a)( b)
Fig. 5. The P-values (MW, Bonf) for APPDWT coefﬁcients plotted in log10-scale against the difference of the mean spectra for the wavelet scales L1–L9.
(a) All P-values. (b) Only the 100 smallest P-values showing the most discriminative parts of the biomarker patterns.
Table 3. Indication of whether the peaks (denoted by their m/z-values, in
Da) are reconstructed by the most signiﬁcant APPDWT coefﬁcients
P-values 1208 1265 1352 1467 1692 1780 1867 2024
1
√
10
√√√
20
√√√ √
50
√√√√ √
150
√√√√ √√√
300
√√√√√√√√
Signiﬁcance order 5 1 2.5 2.5 8 6.5 6.5 4
CPT signiﬁcance order 4 2 3 1 9 7 5 15
TheMWtestisused.Thesign‘
√
’indicatesthepresenceofthepeakinthecorresponding
features.Thistableshowsinparticularthatthelargestpeaksarenotthemoststatistically
signiﬁcant(discriminative)ones.Thesigniﬁcanceordersummarizesthetable.The‘CPT
signiﬁcance order’ is calculated by the CPT software.
Considering the most discriminative parts of the biomarker
patterns (Figure 5b depicts only the 100 smallest P-values), the
discriminative power of the peak is not simply expressed by its
height. For example, the high intensity difference of the peak
at 1867Da is not found among the most discriminative features
obtained. To provide more information for this observation, we
did a further evaluation. For different numbers of the coefﬁcients
with the smallest P-values we plotted the diagram as in Figure 5b
and checked whether the dark cells (discriminative coefﬁcients)
correspond to the peaks of largest intensity difference. This
compares step-by-step the discriminative power of these peaks.
Table 3 shows whether the considered peaks are present in the most
discriminative parts of the biomarkers corresponding to different
quantities of the smallest P-values or not. It turns out that the most
discriminative (the most signiﬁcant one, signiﬁcance order 1) peak
is at 1265Da.
We compared these results also with the most signiﬁcant peaks
produced by CPT 2.2 which uses a t-test based on the peaks areas,
see Table 3, row ‘CPT signifance order’ (for more CPT results see
Supplementary Table 2). CPT ﬁnds a similar set of peaks (the group
of the ﬁrst three peaks is the same) though there are variations in
theirorder.Unfortunately,TRRcannotbecomparedasCPT2.2does
not implement double CV.
Finally the TRR and the generalization properties of classiﬁers
which use only a limited number of the most discriminative
Table 4. Generalization properties of the most discriminative APPDWT
coefﬁcients considering the number of support vectors
Number of coefﬁcients TRR Mean number of SV
1784 (Bonf) 97.3 43.4
100 95.5 39.5
50 94.6 49.5
20 94.6 62.8
10 95.5 66.8
5 95.5 70.0
1 95.5 88.2
The MW test is used to calculate the P-values and to rank the coefﬁcients. For
abbreviations, see Table 2.
wavelet coefﬁcients (Table 4) have been analyzed. As before, the
generalizability of a SVM-classiﬁer is estimated by the number of
support vectors. It may be unexpected to discover that the TRR
providedbyaverysmallnumberandbythousandsofcoefﬁcientsare
comparable. Nevertheless, the classiﬁers constructed using only a
few coefﬁcients need many support vectors.As an extreme example,
themostdiscriminativecoefﬁcientonitsownprovidesarecognition
rate of 95.5%, but the classiﬁer built on it is not general at all, as
88 spectra (almost 4/5 of the dataset) are used as (in this case one
dimensional) SVM support vectors. The large number of support
vectors used (compared with 43 for Bonf) most probably indicates
overﬁtting.
3.4 Possible modiﬁcations
The whole model building and validation procedure needs much
computation time. This is mainly due to the two-level grid search
and leave-one-out cross validation used in the outer loop. Time
could be saved by preselecting the m/z-intervals based on the mean
spectra difference, e.g. by taking only coefﬁcients from the intervals
with an absolute difference larger than a fraction M (0<M<1) of
the maximum absolute difference value. For M=0.05 the intervals
constitute 1.6% of all m/z-values but include all the most signiﬁcant
peaks presented in Table 3.
Another way to reduce computation time is to use only selected
levels of the DWT. In our dataset the typical peak width is ∼30Da
(empirically estimated). On the 5-th DWT level the width of scaling
function is ∼32Da (15 and 65Da for 4-th and 6-th levels). Thus the
scaling function of the 5-th level is a good approximation for peak.
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This was conﬁrmed by tests (Supplementary Table 3). Among the
test runs with individual levels the best results were obtained for
level 5 with the KS test and Bonf adjustment (97.32% TRR and a
mean of 43 support vectors).
4 CONCLUSIONS
We evaluated an automatic procedure of CRC detection using
MALDI-TOF spectra based on: (i) discrete wavelet transformation;
(ii) selection of discriminative wavelet coefﬁcients using the non-
parametric difference tests with multiplicity adjustment; (iii) SVM
classiﬁcation. Our procedure is based on the ideas published
in Schleif et al. (2007), but was signiﬁcantly extended as it was
summarized in the introduction.
Especially, we evaluated the feature selection here together
with the classiﬁcation using an up-to-date double CV scheme to
reduce potential bias. Moreover, we proposed a visualization of the
biomarker patterns used for classiﬁcation.
The presented procedure has been applied to a collection of
MALDI-TOF serum protein proﬁles from 66 CRC patients and 50
controls (de Noo et al., 2006). Compared with (de Noo et al., 2006),
a higher TRR, sensitivity and speciﬁcity for the detection of cancer
are achieved. Examining the properties of SVM classiﬁers with a
different number of wavelet coefﬁcients reveals that the number of
required support vectors goes up signiﬁcantly if too few coefﬁcients
areused.Evenifsuchasmallsubsetgivesgoodclassiﬁcationresults
it indicates an overﬁtting to the given spectra and might indicate
a lack of generalizability of the model considering experimental
variability.
The biomarker patterns provided are similar to those of de Noo
et al. (2006) but have a higher resolution that in principle allows to
ﬁnd minor discriminating peaks close to other neighboring peaks.
The investigation of the found peaks showed that those of them
which intensity-wise differ the most between cancer and control
spectraarenotthemostdiscriminativeonesintermsofthestatistical
feature selection procedure.
We expect that applying our DWT-based classiﬁcation approach
with attention to generalization properties of classiﬁers, helps to
obtain high recognition rates for the detection of cancer and to ﬁnd
biologically valuable and interpretable biomarkers. The molecular
identiﬁcation of the peaks and multi-laboratory validation of the
experimental methods and the classiﬁcation model is beyond the
scope of this article. Based on the m/z-values of linear TOF spectra
an identiﬁcation is not possible and further biochemical and MS/MS
experiments are required.
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